AKT1 and neoplasm: There was no significant change in the expression of miR-182-5p in tumor tissues of mice treated with EVs + miR-182-5p inhibitor + si-CMTM7, while the expression of CMTM7 was reduced, and the EGFR and AKT phosphorylation levels were significantly increased.